Homo sapiens Systemic RNA Interference-defective-1 Transmembrane Family Member 1 (SIDT1) Protein Mediates Contact-dependent Small RNA Transfer and MicroRNA-21-driven Chemoresistance

被引:59
作者
Elhassan, Mohamed O. [1 ,2 ]
Christie, Jennifer [2 ]
Duxbury, Mark S. [1 ,2 ]
机构
[1] Univ Edinburgh, Royal Infirm, Edinburgh EH16 4SA, Midlothian, Scotland
[2] Western Gen Hosp, Pancreat Canc Biol Grp, Edinburgh Canc Res UK Ctr, Inst Genet & Mol Med, Edinburgh EH4 2XR, Midlothian, Scotland
关键词
GAP JUNCTIONAL COMMUNICATION; SHORT INTERFERING RNA; TUMOR-NECROSIS-FACTOR; PHASE-I; CARCINOMA CELLS; DOWN-REGULATION; GEMCITABINE; MICRORNA; MECHANISMS; EXPRESSION;
D O I
10.1074/jbc.M111.318865
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Locally initiated RNA interference (RNAi) has the potential for spatial propagation, inducing posttranscriptional gene silencing in distant cells. In Caenorhabditis elegans, systemic RNAi requires a phylogenetically conserved transmembrane channel, SID-1. Here, we show that a human SID-1 orthologue, SIDT1, facilitates rapid, contact-dependent, bidirectional small RNA transfer between human cells, resulting in target-specific non-cell-autonomous RNAi. Intercellular small RNA transfer can be both homotypic and heterotypic. We show SIDT1-mediated intercellular transfer of microRNA-21 to be a driver of resistance to the nucleoside analog gemcitabine in human adenocarcinoma cells. Documentation of a SIDT1-dependent small RNA transfer mechanism and the associated phenotypic effects on chemoresistance in human cancer cells raises the possibility that conserved systemic RNAi pathways contribute to the acquisition of drug resistance. Mediators of non-cell-autonomous RNAi may be tractable targets for novel therapies aimed at improving the efficacy of current cytotoxic agents.
引用
收藏
页码:5267 / 5277
页数:11
相关论文
共 62 条
[1]
A PHASE-I CLINICAL, PLASMA, AND CELLULAR PHARMACOLOGY STUDY OF GEMCITABINE [J].
ABBRUZZESE, JL ;
GRUNEWALD, R ;
WEEKS, EA ;
GRAVEL, D ;
ADAMS, T ;
NOWAK, B ;
MINEISHI, S ;
TARASSOFF, P ;
SATTERLEE, W ;
RABER, MN ;
PLUNKETT, W .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (03) :491-498
[2]
Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells [J].
Ammerpohl, O. ;
Trauzold, A. ;
Schniewind, B. ;
Griep, U. ;
Pilarsky, C. ;
Grutzmann, R. ;
Saeger, H-D ;
Janssen, O. ;
Sipos, B. ;
Kloppel, G. ;
Kalthoff, H. .
BRITISH JOURNAL OF CANCER, 2007, 96 (01) :73-81
[3]
Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells [J].
Bachem, MG ;
Schünemann, M ;
Ramadani, M ;
Siech, M ;
Beger, H ;
Buck, A ;
Zhou, SX ;
Schmid-Kotsas, A ;
Adler, G .
GASTROENTEROLOGY, 2005, 128 (04) :907-921
[4]
Identification, culture, and characterization of pancreatic stellate cells in rats and humans [J].
Bachem, MG ;
Schneider, E ;
Gross, H ;
Weidenbach, H ;
Schmid, RM ;
Menke, A ;
Siech, M ;
Beger, H ;
Grünert, A ;
Adler, G .
GASTROENTEROLOGY, 1998, 115 (02) :421-432
[5]
Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line [J].
Bai, Haitao ;
Xu, Rang ;
Cao, Zhongwei ;
Wei, Daolin ;
Wang, Chun .
FEBS LETTERS, 2011, 585 (02) :402-408
[6]
Bantly Andrew D, 2007, Immunol Invest, V36, P581, DOI 10.1080/08820130701712461
[7]
RNA silencing in plants [J].
Baulcombe, D .
NATURE, 2004, 431 (7006) :356-363
[8]
Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer [J].
Bhargava, P ;
Marshall, JL ;
Fried, K ;
Williams, M ;
Lefebvre, P ;
Dahut, W ;
Hanfelt, J ;
Gehan, E ;
Figuera, M ;
Hawkins, MJ ;
Rizvi, NA .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (02) :95-103
[9]
Small RNAs are on the move [J].
Chitwood, Daniel H. ;
Timmermans, Marja C. P. .
NATURE, 2010, 467 (7314) :415-419
[10]
Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy [J].
Cottin, Sylvine ;
Ghani, Karim ;
de Campos-Lima, Pedro Otavio ;
Caruso, Manuel .
MOLECULAR CANCER, 2010, 9